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Abstract The molecular interactions of poly(ADP-ribose)
polymerase I (PARP I) and topoisomerase I (Topo I) have been
determined by the analysis of physical binding of the two proteins
and some of their polypeptide components and by the effect of
PARP I on the enzymatic catalysis of Topo I. Direct association
of Topo I and PARP I as well as the binding of two Topo I
polypeptides to PARP I are demonstrated. The effect of PARP I
on the ‘global’ Topo I reaction (scission and religation), and the
activation of Topo I by the 36 kDa polypeptide of PARP I and
catalytic modifications by poly(ADP-ribosyl)ation are also
shown. The covalent binding of Topo I to circular DNA is
activated by PARP I similar to the degree of activation of the
‘global’ Topo I reaction, whereas the religation of DNA is
unaffected by PARP I. The geometry of PARP I^Topo I
interaction compared to automodified PARP I was reconstructed
from direct binding assays between glutathione S-transferase
fusion polypeptides of Topo I and PARP I demonstrating highly
selective binding, which was correlated with amino acid
sequences and with the ‘C clamp’ model derived from X-ray
crystallography. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
Poly(ADP-ribose) polymerase I (PARP I) is known to as-
sociate with itself [1] and with numerous nuclear proteins [2],
consisting of enzymes, cell speci¢c transcriptional factors [3]
and other transcriptional regulators (cf. [4]), suggesting that
the cellular function of PARP I, besides signaling single
strand DNA cuts [5,6], most likely includes a control of spe-
ci¢c gene expressions. It was ¢rst reported in 1983 [7,8] that
PARP I in the presence of NAD poly(ADP-ribosyl)ates topo-
isomerase I (Topo I) resulting in enzyme inhibition. In the
absence of NAD a direct binding of PARP I to Topo I
with concomitant enzymatic activation of Topo I occurs, as
assayed by the conventional DNA unwinding test [9,10]. Ki-
netic analyses indicate a binding between Topo I and PARP I,
as well as with circular DNA [9], which is supercoiled by
PARP I association [11], thus favoring its substrate function
in the Topo I catalyzed process [9]. Since the enzymatic mech-
anism of Topo I has been signi¢cantly clari¢ed [12^14], fur-
ther questions relevant to the activation of Topo I by PARP I
could be asked. These are: (a) what portion of the PARP I
polypeptide is required for Topo I activation, as well as (b)
what domains of Topo I can bind to PARP I, and (c) can the
assay for covalent adduct formation between circular DNA
and Topo I or the religation test for Topo I [14] demonstrate
activation by PARP I? Experimental analyses of these ques-
tions, as described here, permit formulation of a preliminary
structural interpretation of the PARP I/Topo I association.
2. Materials and methods
2.1. Isolation of PARP I and Topo I from calf thymus
This technique and the ultimate separation of the two proteins from
calf thymus are reported in [2,9].
2.2. Western overlay analyses of the binding of PARP I to Topo I
32P labeled Topo I was prepared by ¢rst dephosphorylating Topo I
[9] with alkaline phosphatase bound Sepharose 4B resin (Sigma) by
incubation of Topo I for 3 h at 25‡C in 0.1 M Tris^HCl, pH 8.0.
After centrifugal sedimentation of the resin the bu¡er was changed to
0.1 M Tris^HCl (pH 7.4) containing 10% glycerol in a Centricon 30
¢lter. The dephosphorylated Topo I was rephosphorylated by protein
kinase CK as reported for PARP I [15] with [32P]ATP, resulting in 32P
labeled Topo I with a speci¢c activity of 1500 dpm/Wg protein. The
overlay assay was carried out as reported [2].
2.3. Binding of 125I labeled PARP I or 32P labeled PARP I to Topo I
and its polypeptides
Topo I polypeptides were generated by digestion of Topo I with
chymotrypsin [9,16], followed by their electrophoretic separation and
transblotting. Polypeptides were incubated either with 125I labeled
PARP I (cf. [2]) (4U106 dpm) or with 32P labeled PARP I (2U106
dpm, cf. [2]) at 25‡C, and autoradiographed [2].
2.4. Poly(ADP-ribosyl)ation of Topo I and its peptide fragments
This operation was carried out in situ, after electrophoretic separa-
tion and transblot to nitrocellulose membranes, followed by incuba-
tion with 50 WCi [32P]NAD and 200 WM NAD in 10 ml medium
(100 mM Tris^HCl, pH 8.0), 7 mM 2-mercaptoethanol, 0.1 M NaCl,
20 Wg/ml co-enzymic DNA (cf. [21]) and 2 Wg PARP I [9] for 30 min
at 25‡C. This incubation was followed by 3U10 ml wash with Tris^
HCl (pH 7.5) bu¡er, twice with 10 ml of the same bu¡er containing
0.1 M NaCl and 0.02% SDS, then with 10 ml Tris^HCl (pH 7.4)
bu¡er without NaCl or SDS (each wash for 5 min), and then dried
and autoradiographed overnight.
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2.5. Preparation of the 36 kDa and 52 kDa polypeptide fragments of
PARP I
The polypeptide fragments were prepared as reported previously
[16].
2.6. Religation assay
The religation assay for Topo I was done as published [14].
2.7. Preparation of glutathione S-transferase (GST) fusion proteins of
Topo I domains
These were prepared as described [17] and the pull down assay of
GST fusion peptides by PARP I was done by standard techniques.
2.8. Poly(ADP-ribose) polymers
Poly(ADP-ribose) polymers were prepared as described earlier
[19,20]
3. Results and discussion
As the results of overlay of isolated polypeptides with either
32P or 125I labeled PARP I or 32P labeled Topo I, Fig. 1 shows
the binding of 32P labeled Topo I to PARP I (Fig. 1A) and
125I labeled and 32P labeled PARP I to Topo I as well as of
two of its proteolytic polypeptides to Topo I (Fig. 1B). The
lower band in Fig. 1A represents traces of proteolytic degra-
dation products of PARP I which also bound 32P labeled
Topo I. The poly(ADP-ribosyl)ation of Topo I and two of
its chymotryptic peptides is illustrated in Fig. 1C. Only two
out of ¢ve major chymotryptic polypeptides of Topo I (75 and
60 kDa) were poly(ADP-ribosyl)ated (cf. [9]) indicating mod-
i¢cation of the N-terminus of Topo I.
The activity of Topo I, assayed by the unwinding^religation
test as reported [9], exhibits characteristic variations depending
on speci¢c additions as shown in Fig. 2. In lane 1 the base
activity of Topo I is shown as 100%, and lane 2 illustrates
800% activation by added 0.2 Wg PARP I. The 36 kDa pro-
teolytic fragment of PARP I activates Topo I by about 50%
compared to intact PARP I (lane 3), whereas the 52 kDa
PARP I fragment has lost nearly all activating action. The
36 kDa polypeptide of PARP I also binds to DNA [2], there-
fore the coincidence of DNA binding and Topo I activation
suggests that Topo I activation by PARP I also involves DNA
binding, as found experimentally [9]. Poly(ADP-ribosyl)ated
Topo I has very low activity (lane 5), con¢rming earlier re-
ports [7,8], and poly(ADP-ribosyl)ated PARP I is also inhib-
itory to Topo I (lane 6). Preincubation of Topo I with PARP
I+NAD+co-enzymic DNA abolishes the activation of Topo
I by PARP I (lane 7), but an inhibitor of PARP I (1 mM
benzamide) largely restores the activation of Topo I. The
poly(ADP-ribose) polymers do not inhibit Topo I when added
in the form of free polymers (lane 9).
Fig. 1. Binding of PARP I to Topo I and its chymotryptic polypep-
tide fragments. PARP I (1.2 Wg, A) or Topo I (1 Wg, lanes 1 and 3
in B and lane 1 in C) and chymotryptic fragments (lanes 2 and 4 in
B, and lane 2 in C) were separated by electrophoresis, transblotted
and renatured (cf. [2]). Polypeptide fragments of Topo I were ob-
tained by digestion of 3 Wg of Topo I (cf. [2]). The PARP I contain-
ing blots were overlaid (see Section 2) with 32P labeled Topo I (A).
The Topo I containing blots (B) were incubated either with
[32P]PARP I (lanes 1 and 2, B) or with [125I]PARP I (lanes 3 and 4,
B). C: Autoradiography of in situ poly(ADP-ribosyl)ated Topo I
and two of its chymotryptic fragments. In lane 2 of C there are
traces of undigested Topo I (top line). Identical results were ob-
tained in triplicate separate experiments.
Fig. 2. E¡ects of PARP I and its poly(ADP-ribosyl)ation and the
36 and 52 kDa PARP I fragments and of the free poly(ADP-ribose)
polymer on Topo I activity. Topo I activity was assayed quantita-
tively as reported [9]. One unit of activity was de¢ned as 100% ac-
tivity (i.e. the amount of Topo I required to relax 50% of the plas-
mid, cf. [9]). This is shown in lane 1. Lane 2 illustrates the
activation by 0.2 Wg PARP I, lane 3 the e¡ect of 0.3 Wg of 36 kDa
PARP I fragment, lane 4 that of 0.4 Wg of the 52 kDa PARP I
fragment. Inhibition of Topo I (0.2 Wg) by its poly(ADP-ribosyl)-
ation is illustrated in lane 5, whereas inhibition of Topo I by 0.2 Wg
poly(ADP-ribosyl)ated PARP I is shown in lane 6. The inhibitory
action of in situ poly(ADP-ribosyl)ation of 0.2 Wg PARP I (carried
out for 10 min) is demonstrated in lane 7, and the rescue by 1 mM
benzamide in lane 8. Lane 9 illustrates the absence of inhibitory ef-
fect of 1 Wg (long chain (cf. [19,20]) free poly(ADP-ribose). Results
are the average of four experiments with S.D. error bars shown.
Fig. 3. E¡ects of PARP I on the covalent Topo I^DNA complex
formation step of Topo I catalysis. The binding of Topo I (1 Wg) to
circular DNA was assayed by the ¢ltration technique as reported
(cf. [11]). The DNA^Topo I covalent complex was stabilized by 20
WM camptothecin. Ordinate (cpm): [3H]DNA (SV3 neo plasmid,
100 ng) bound to Topo I; abscissa: no PARP I added, +1 Wg
PARP I added. Results show the average of three separate experi-
ments with S.D. error bars shown.
FEBS 25315 5-10-01
P.I. Bauer et al./FEBS Letters 506 (2001) 239^242240
The activation mechanism of PARP I on Topo I was fur-
ther studied by determining the binding of 3H labeled super-
coiled circular DNA to Topo I in the presence of PARP I (cf.
[9]) and camptothecin (20 WM), which stabilizes the Topo I^
DNA adduct as shown in Fig. 3. There is a six-fold increase
of DNA binding to Topo I in the presence of 1 Wg PARP I
demonstrating that the rates of scission of the phosphodiester
bond and binding of Topo I to DNA are accelerated by
PARP I.
The e¡ect of PARP I on the DNA religation assay (cf. [13])
is illustrated in Fig. 4. In contrast to the activation of Topo I
by PARP I, as assayed by either the global reaction (scission
and religation) where velocity is de¢ned as the time required
for 50% unwinding of plasmid DNA, or by the binding of
Topo I to plasmid DNA the DNA adduct being stabilized by
camptothecin (Fig. 3), the rates of religation of DNA by Topo
I are una¡ected by PARP I (Fig. 4). These results suggest that
religation may not be rate limiting in topoisomerization that is
probably determined by rates of preceding steps (scission of
phosphodiester bond in DNA and binding to DNA itself),
which are directly activated by the binding of PARP I.
The identi¢cation of the Topo I domains that speci¢cally
bind to PARP I was done with the aid of GST fusion peptides
(cf. [17]) by the pull down technique. Results are summarized
in Fig. 5A,B. In the pull down assay, 0.2 Wg Topo I fragments
(10^40 Wl gel slurry), containing bound GST polypeptides ex-
pressed in XL-1 blue cells (cf. [17]) were incubated with 0.2 Wg
PARP I (panel A) or 0.25 Wg poly(ADP-ribosyl)ated PARP I
(panel B) and then processed (see Section 2) to identify PARP
I containing complexes by immunoblots (cf. [2]). Polypeptides
of Topo I present in GT-4, 5 and GT-8, 9 bound speci¢cally
to PARP I. The binding of poly(ADP-ribosyl)ated PARP I to
the GST fusion fragments is shown in Fig. 5B. GT fragments
1, 2 and 4, 5 bind to poly(ADP-ribosyl)ated PARP I. The
unconjugated GST protein exhibited no binding to PARP I
or poly(ADP-ribosyl)ated PARP I (lanes 10 in A and B).
Based on the X-ray crystallographic analysis [12^14] of
Topo I, a ‘C clamp’ model has been formulated [18]. The
topology scheme of PARP I^Topo I interactions (Fig. 6) takes
advantage of the X-ray model and is reconstructed from bind-
Fig. 4. The e¡ect of PARP I on the religation reaction of Topo I
catalysis. Each assay contained 105 dpm 32P labeled double stranded
DNA (cf. [14]) with covalently attached Topo I (0.2 Wg) with or
without added PARP I (0.4 Wg). The reaction was started by addi-
tion of 100-fold excess of displacing single stranded oligo-DNA [14]
and incubation continued at 25‡C. Aliquots were withdrawn at 1, 5,
15, 30, and 45 min and quenched with 0.5% SDS, then treated with
proteinase K (0.5 mg/ml) at 52‡C (60 min), heated to 95‡C (1 min)
in formamide containing loading bu¡er and electrophoresed in a
20% PAGE gel containing 8 M urea. The location of religated oli-
go-DNA was done by autoradiography and quantitated by liquid
scintillation. The ¢gure shows ¢rst order rate constants calculated
from two parallel assays.
Fig. 5. The binding of free and poly(ADP-ribosyl)ated PARP I to
Topo I fragments expressed as GST fusion proteins. In both A and
B the abscissa shows the identi¢cation of GST polypeptides, which
de¢nes localization of binding (in terms of amino acid residues).
The ordinate indicates separation of bound PARP I (A) as identi-
¢ed by Western immunoblot or poly(ADP-ribosyl)ated PARP I (B).
The abscissa shows the number of GST fusion peptides. Lane 10:
GST.
Fig. 6. Summary of topologic interpretation of Topo I^PARP I in-
teractions. PARP I^Topo I and (ADPR)n^PARP I^Topo I binding
sites, deduced from the ‘C clamp’ model and results shown in Fig.
4. A and B illustrate the ‘C clamp’ conformation, with numbered
location of GST^Topo I fragment fusion proteins as projected from
D, which is a linear sequence of GST^Topo I fragments correlated
with amino acid sequences given in C. B depicts the binding of
PARP I (solid ellipsoid) and poly(ADP-ribosyl)ated PARP I
(dashed ellipsoid) to Topo I. E is a summary of amino acid sequen-
ces identi¢ed for the binding sites of PARP I (second and third
bars) and for (ADPR)n^PARP I (¢rst and second bars).
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ing results (Fig. 5) between PARP I and GST fusion polypep-
tides of Topo I (see Fig. 6A,C,D). The truncated N-terminal
domain of Topo I (aa 1^214) corresponding to GT-1^3 lacks
ordered structure, is highly positively charged [13], and is
responsible for the binding of several proteins (e.g. nucleolin,
p53 and modi¢ed PARP I). The core domain (GT-3^6, aa
215^635) clamps DNA and contains amino acids Arg-488,
Arg-590, and His-632 (cf. [14]), which contribute to the cata-
lytic site of Topo I (Fig. 6), whereas the C-terminus (aa 712^
765 corresponding to GT-8, 9) contains Tyr-723, which is
thought to exert a nucleophilic attack on the scissible phos-
phodiester bond of DNA. The linker (aa 636^712) separates
the core and C-terminal domains and corresponds to GT-7
and in part to GT-8 and GT-9.
The binding of PARP I (solid ellipsoid line in Fig. 6B,
identi¢ed as PARP) and that of the poly(ADP-ribosyl)ated
PARP I (dashed ellipsoid line in Fig. 6B, identi¢ed as auto-
modi¢ed PARP) are shown as amino acid sequences in Fig.
6E. This interpretation is derived from results given in Fig.
5A,B. The binding sites of the unmodi¢ed PARP I may ex-
plain the activation by providing a more ‘tight ¢sted’ Topo I
DNA structure [9] that promotes rates of enzymatic catalysis
(scission of phosphodiester in DNA and binding to DNA).
On the other hand, the poly(ADP-ribosyl)ated PARP I binds
to GT-1, 2 and GT-4, 5, which are not in the vicinity of the
catalytic center, yet this binding may countermand the con-
formation changes required for catalytic function. In agree-
ment with this mechanism, it is apparent from results shown
in Fig. 2, notably lane 6, that poly(ADP-ribosyl)ated PARP I
inhibits Topo I. The free poly(ADP-ribose) polymer has no
e¡ect on the enzymatic process of Topo I (Fig. 2, lane 9),
whereas poly(ADP-ribosyl)ation of Topo I most probably re-
pels DNA binding, as is also known for certain other DNA
binding proteins (cf. [4,21]).
The topology of PARP I^Topo I binding and its relation-
ship to enzymatic activity complements present enzymatic the-
ories [13,18,22,23] inasmuch as it provides a possible mecha-
nism to improve the contact of the decatenated DNA loop
with Topo I by way of PARP I binding, a process speci¢cally
relevant to eukaryotes.
As we have shown [9] that even highly puri¢ed Topo I of
calf thymus origin or PARP I preparations from the same
source are cross contaminated with each other, it is not sur-
prising that the quasi co-enzymic function of PARP I to Topo
I as proposed here has been overlooked.
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